Molecular diagnostics lab technician
BD MAX™ System - March 22, 2023

Core innovation to address laboratory staff challenges

Sometimes innovation means delivering transformative new-to-world technology to healthcare providers and patients. Innovation can also mean enhancing the products and solutions our customers depend on across the healthcare continuum—products that serve as the backbone of care. This continued innovation in our core portfolio of products and services can meaningfully improve efficiencies, safety, patient experience and ultimately outcomes.  

When you look at the healthcare landscape today, it’s impossible to ignore challenges like burnout, staffing shortages and cost pressures. Because healthcare professionals are being asked to do more with less, in new ways and settings, solutions need to fit into their workflow and to help make their jobs easier. Think flexible, scalable, interoperable.  

Let’s zoom in on how continuing to innovate in our core portfolio can help address some of these challenges by taking a closer look at some recent updates to our benchtop BD MAX™ Molecular Diagnostic System.  


The power of benchtop testing in molecular diagnostics 

Benchtop testing platforms are important because they offer robust diagnostic solutions to labs that they might not otherwise have access to, and without having to extend turn- around time by sending samples to a centralised lab for test. For their space-saving design, they offer an extensive menu of tests for infectious diseases, such as healthcare-associated infections (HAIs), respiratory infections, sexually transmitted infections, and gastrointestinal infections.  

Our benchtop molecular testing platform, the BD MAX™ System, is installed in thousands of hospitals and labs around the world, yet customers helped us to identify unmet needs—like better ergonomics, maximising counter space, and enhancing lab efficiency with on-demand analytics. Because diagnostic testing remains a vital data point in clinician decision-making and treatment plans, every improvement to user experience and functionality that we make to any of our platforms ultimately holds the potential to improve patient care. Continuous improvement is important.  


Responding to your challenges on the BD MAX™ System 

Our research and development team understood that in the daily workings of a busy lab facing time- and resource-challenges, impactful modifications to a platform that lab technicians already relied upon could be a more seamless way to provide the desired improvements. “We listened and responded to our customers’ feedback, and we focused on innovating in areas that would help them most in improving efficiency and workflow,” said Josh Keller, Director of Product Development & Engineering at BD.  

For example, for labs where counter space is at a premium, we introduced a variable height swivel arm mount with keyboard tray to give our customers additional space underneath to process samples and provide optimal viewing and positioning for each individual in the lab. To enable secure connectivity and on-demand analytics for anytime, anywhere access results via an internet browser, we integrated enhanced hardware designed to improve system robustness, and BD Synapsys™ middleware. And to help reduce plastic waste generated in the lab while providing a convenient storage solution for re- testing or reflex testing, we added a resealable septum cap, which can be used also to store specimens after processing. 

“Innovating in our core portfolio means that our customers can enjoy the evolution of a product that they know and trust while we continue to anticipate and meet their needs in years to come,” Keller said.  

To learn more about BD MAX™ PLUS Molecular Diagnostic System can do for your lab, head to our Resources page to download the brochure.

By reading this content you are acknowledging our forward looking statement.

Why join BD MAX™ Club?

Connect with professionals from around the world BD MAX™ Club members represent a community of professionals in infectious diseases and molecular diagnostics. With regional meet-ups and live webinars from global experts, expand your laboratory’s network and collaborate with worldwide colleagues.

Tailored medical and technical expertise Whether you need compelling scientific research or tutorials for troubleshooting on the BD MAX™ System, BD MAX™ Club is here to accompany your molecular diagnostics journey. Sign up now as a BD MAX Club member, to stay in the know of scientific updates and upcoming event(s).

Exclusive members’ perks BD MAX™ Club membership unlocks doors to exclusive webinars and collaboration with industry leading experts. Engage with your colleagues in the molecular community and exchange with the BD research and development team.

Latest news

Forward Looking Statement

The information included on this website and other information provided from time to time through webcasts, conference calls, securities analyst meetings, road show presentations, investor conferences, newsletters and similar events and communications contains forward-looking statements (as defined under Federal securities laws) based on current expectations and assumptions that involve risks and uncertainties. If the risks or uncertainties ever materialize or the assumptions prove incorrect, the results of BD may differ materially from those expressed or implied by such forward-looking statements and assumptions. Forward-looking statements may be identified by the use of words such as “plan,” “expect,” “believe,” “intend,” “will,” “may,” “anticipate,” “estimate” and other words of similar meaning in conjunction with, among other things, discussions of future operations and financial performance (including volume growth, pricing, sales and earnings per share growth, and cash flows) and statements regarding our strategy for growth, future product development, regulatory approvals, competitive position and expenditures.

All such statements are based upon current expectations of BD and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement. Many of these risks and uncertainties are beyond the company’s control. For a discussion of certain factors that could cause our actual results to differ from our expectations in any forward-looking statements see our latest Annual Report on Form 10-K and other filings with the SEC. BD expressly disclaims any undertaking to update or revise any forward looking statements set forth herein to reflect events or circumstances after the date hereof, except as required by applicable law or regulation.